Moreover, in a research on triple‐negative breast cancer (TNBC), heparin‐binding epidermal growth factor (HB‐EGF) was found to play a pivotal role in the acquisition of tumor aggressiveness by regulating both ANGPTL4 and VEGFA.52 The gene discussed is ANGPTL4; the disease is neoplasm.